Investor Regals Capital Management Lp
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Regals Capital Management Lp . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2018-06-19 13G TNXP / Tonix Pharmaceuticals Holding Corp. 430,519
2017-02-14 13G/A ARCT / Arcturus Therapeutics Holdings Inc. 1,716,377 1,720,725
2016-02-16 13G/A ARCT / Arcturus Therapeutics Holdings Inc. 1,028,529 1,716,377
2016-02-16 13G/A ORMP / Oramed Pharmaceuticals Inc. 1,880,138
2015-10-14 13G ARCT / Arcturus Therapeutics Holdings Inc. 1,028,529
2015-02-13 13G/A ORMP / Oramed Pharmaceuticals Inc. 1,453,637
2014-02-06 13G/A ORMP / Oramed Pharmaceuticals Inc. 1,376,385
2013-02-21 13D/A LGDI / Legend International Holdings, Inc. 115,345,195
2013-02-12 13G/A ORMP / Oramed Pharmaceuticals Inc. 1,317,914
2012-09-06 13G/A ORMP / Oramed Pharmaceuticals Inc. 13,029,698
2012-08-17 13D LGDI / Legend International Holdings, Inc. 70,345,195
2012-06-27 13G/A LGDI / Legend International Holdings, Inc. 46,914,015
2012-06-13 13G/A LGDI / Legend International Holdings, Inc. 24,273,290
2012-04-13 13G ORMP / Oramed Pharmaceuticals Inc. 6,961,737
2012-03-08 13G/A LGDI / Legend International Holdings, Inc. 22,543,531